Obesity: presenter slides
Sibutramine (Reductil): marketing authorisation suspended
On 21 January 2010, the MHRA announced the suspension of the marketing authorisation for the obesity drug sibutramine (Reductil)
The slide set has been updated to reflect this change.
Most NICE guidance will be accompanied by a slide set. The slide sets provide a framework for discussion with a variety of audiences. They can be tailored for local presentations. The slide sets contain key messages - they do not cover all recommendations.
This slide set contains key messages for prevention for local authorities, early years' settings, schools, self help commercial and community settings, workplaces and the NHS. For the NHS, the slide set also includes recommendations for identification, assessment and management.
We welcome feedback on how useful our slide sets are. Please email comments to firstname.lastname@example.org.
Please note that the slide sets may not function correctly when opened within Internet Explorer. Save the presentation to your PC by clicking on the link below and selecting 'Save', or by right clicking and selecting 'Save Target As'. Saving the presentation will allow you to open it in PowerPoint, where you can view the presenter notes, or edit the slide sets for your own purposes.
This slide set is an implementation tool and should be used alongside the published guidance. This information does not supersede or replace the guidance itself.
This page was last updated: 26 January 2011